Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on January 5, 2004

Circulation. 2004
Published online before print January 5, 2004, doi: 10.1161/01.CIR.0000109498.77895.6F
A more recent version of this article appeared on January 27, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/3/399    most recent
01.CIR.0000109498.77895.6Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Federici, M.
Right arrow Articles by Consoli, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Federici, M.
Right arrow Articles by Consoli, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Endothelium/vascular type/nitric oxide

Submitted on February 26, 2003
Revised on September 22, 2003
Accepted on September 22, 2003

G972R IRS-1 Variant Impairs Insulin Regulation of Endothelial Nitric Oxide Synthase in Cultured Human Endothelial Cells

Massimo Federici MD, Assunta Pandolfi PhD, Elena Anna De Filippis MD, Giuliana Pellegrini PhD, Rossella Menghini PhD, Davide Lauro MD, Marina Cardellini MD, Mario Romano MD, Giorgio Sesti MD, Renato Lauro MD, and Agostino Consoli MD*

From the Department of Internal Medicine University of Tor Vergata, Rome (M.F., R.M., D.L., M.C., R.L.); the Departments of Biomorphology (A.P.), Medicine and Aging Sciences (E.A.D., G.P., A.C.), and Biomedical Sciences (M.R.), Centro Scienze Invecchiamento, University d’Annunzio, Chieti; and the Department of Clinical and Experimental Medicine, University of Catanzaro (G.S.), Italy.

* To whom correspondence should be addressed. E-mail: consoli{at}unich.it.

Background--Impaired insulin-mediated vasodilation might contribute to vascular damage in insulin-resistant states. Little is known about insulin regulation of nitric oxide (NO) synthesis in insulin-resistant cells. The aim of this work was to investigate insulin regulation of NO synthesis in human umbilical vein endothelial cells (HUVECs) carrying the IRS-1 gene G972R variant, known to be associated with impaired insulin activation of the PI3-kinase (PI3-K) pathway in transfected cells.

Methods and Results--HUVECs were screened for the presence of the G972R-IRS-1 (HUVEC-G972R) variant by restriction fragment length polymorphisms. After 24-hour exposure to 10-7 mol/L insulin, endothelial NO synthase (eNOS) mRNA (reverse transcription-polymerase chain reaction), eNOS protein levels (Western blotting), and NOS activity (conversion of [3H]arginine into [3H]citrulline) were increased in wild-type HUVECs (HUVEC-WT), whereas they did not change from baseline in HUVEC-G972R. Compared with HUVEC-WT, in HUVEC-G972R after 2 and 10 minutes of insulin stimulation, IRS-1-associated PI3-K activity was reduced by 47% and 32%, respectively; Akt phosphorylation was decreased by 40% at both time points; and eNOS-Ser1177 phosphorylation was reduced by 38% and 51%, respectively. In HUVEC-WT, eNOS-Thr495 phosphorylation decreased after insulin stimulation. In contrast, in HUVEC-G972R, eNOS-Thr495 phosphorylation increased after insulin stimulation and was 40% greater than in HUVEC-WT.

Conclusions--Our data demonstrate that genetic impairment of the (IRS)-1/PI3-K/PDK-1/Akt insulin signaling cascade determines impaired insulin-stimulated NO release and suggest that the G972R-IRS-1 polymorphism, through a direct impairment of Akt/eNOS activation in endothelial cells, may contribute to the genetic predisposition to develop endothelial dysfunction and cardiovascular disease.


Key words: endothelium • insulin • nitric oxide synthase




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Andreozzi, G. Formoso, S. Prudente, M. L. Hribal, A. Pandolfi, E. Bellacchio, S. Di Silvestre, V. Trischitta, A. Consoli, and G. Sesti
TRIB3 R84 Variant Is Associated With Impaired Insulin-Mediated Nitric Oxide Production in Human Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1355 - 1360.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Consoli, E. Martelli, M. D'Adamo, R. Menghini, D. Arcelli, O. Porzio, A. Pandolfi, G. R. Pistolese, A. Consoli, R. Lauro, et al.
Insulin Resistance Affects Gene Expression in Endothelium
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): e7 - e9.
[Full Text] [PDF]


Home page
Exp PhysiolHome page
M. T. Kearney, E. R. Duncan, M. Kahn, and S. B. Wheatcroft
Insulin resistance and endothelial cell dysfunction: studies in mammalian models
Exp Physiol, January 1, 2008; 93(1): 158 - 163.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. Marchetti, R. Menghini, S. Rizza, A. Vivanti, T. Feccia, D. Lauro, A. Fukamizu, R. Lauro, and M. Federici
Benfotiamine Counteracts Glucose Toxicity Effects on Endothelial Progenitor Cell Differentiation via Akt/FoxO Signaling.
Diabetes, August 1, 2006; 55(8): 2231 - 2237.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-a Kim, M. Montagnani, K. K. Koh, and M. J. Quon
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms
Circulation, April 18, 2006; 113(15): 1888 - 1904.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Naruse, C. Rask-Madsen, N. Takahara, S.-w. Ha, K. Suzuma, K. J. Way, J. R.C. Jacobs, A. C. Clermont, K. Ueki, Y. Ohshiro, et al.
Activation of Vascular Protein Kinase C-{beta} Inhibits Akt-Dependent Endothelial Nitric Oxide Synthase Function in Obesity-Associated Insulin Resistance
Diabetes, March 1, 2006; 55(3): 691 - 698.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. A. Ferreira, A. I.M. Mocking, M. A.H. Feijge, G. Gorter, T. W. van Haeften, J. W.M. Heemskerk, and J.-W. N. Akkerman
Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus
Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 417 - 422.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Pandolfi, A. Solini, G. Pellegrini, G. Mincione, S. Di Silvestre, P. Chiozzi, A. Giardinelli, M. C. Di Marcantonio, A. Piccirelli, F. Capani, et al.
Selective Insulin Resistance Affecting Nitric Oxide Release But Not Plasminogen Activator Inhibitor-1 Synthesis in Fibroblasts From Insulin-Resistant Individuals
Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2392 - 2397.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. G. Haider, R. A. Bucek, A. G. Giurgea, G. Maurer, H. Glogar, E. Minar, M. Wolzt, M. R. Mehrabi, and M. Baghestanian
PGE1 analog alprostadil induces VEGF and eNOS expression in endothelial cells
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2066 - H2072.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E.J.F. Danson, Y.H. Zhang, C.E. Sears, A.R. Edwards, B. Casadei, and D.J. Paterson
Disruption of inhibitory G-proteins mediates a reduction in atrial {beta}-adrenergic signaling by enhancing eNOS expression
Cardiovasc Res, September 1, 2005; 67(4): 613 - 623.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg
Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation
Circulation, March 22, 2005; 111(11): 1448 - 1454.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Rask-Madsen and G. L. King
Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 487 - 496.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. McGettrick, E. P. Feener, and C. R. Kahn
Human Insulin Receptor Substrate-1 (IRS-1) Polymorphism G972R Causes IRS-1 to Associate with the Insulin Receptor and Inhibit Receptor Autophosphorylation
J. Biol. Chem., February 25, 2005; 280(8): 6441 - 6446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Fulton, M. B. Harris, B. E. Kemp, R. C. Venema, M. B. Marrero, and D. W. Stepp
Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2384 - H2393.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H.-N. Huang, P.-J. Lu, W.-C. Lo, C.-H. Lin, M. Hsiao, and C.-J. Tseng
In Situ Akt Phosphorylation in the Nucleus Tractus Solitarii Is Involved in Central Control of Blood Pressure and Heart Rate
Circulation, October 19, 2004; 110(16): 2476 - 2483.
[Abstract] [Full Text] [PDF]